1. SK Biopharmaceuticals. SK Biopharmaceuticals and Arvelle Therapeutics announce agreement to develop and commercialize cenobamate in Europe [media release]. 2019. http://www.skbp.com.
2. U.S. Food and Drug Administration. FDA approves new treatment for adults with partial-onset seizures [media release]. 2019. https://www.fda.gov.
3. SK Biopharmaceuticals. Cenobamate (XCOPRI): US prescribing information. 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212839s000lbl.pdf. Accessed 27 Nov 2019.
4. SK Biopharmaceuticals. SK Biopharmaceuticals drug program wins funding support from Korean government [media release]. 2012. http://www.skbp.com.
5. World Intellectual Property Organization. Neurotherapeutic azole compounds. 2006. https://patentimages.storage.googleapis.com/cf/e2/9c/8cb63ba5150ea9/WO2006112685A1.pdf. Accessed 3 Dec 2019.